Lung Cancer Clinical Resource Area - Education

ONS Chemotherapy and Biotherapy Trainer Course
In an effort to encourage consistency in practice in the area of chemotherapy administration, ONS has developed a Chemotherapy and Biotherapy Course that is presented throughout the U.S. Learn more about the courses at the link above.

ONS Lung Cancer Online Course
This site specific online course would provide detailed information to help nurses understand the current management of lung cancer. Based on the ONS publication Site-Specific Cancer Series: Lung Cancer, the course will address the following:

• Biology and therapeutic implications
• Cancer control issues
• Patient Assessment
• Oncologic urgencies and emergencies
• Symptom management

ONS Radiation Therapy Course
The content of the one-day course is appropriate for those who are new to radiation therapy as well as for those who would like a comprehensive review on this topic. Principles of radiation therapy, new radiation treatment modalities, and management of side effects are among the course key topics. The ONS Manual for Radiation Oncology Nursing Practice and Education and ONS Radiation Therapy patient Care Record serve as the required texts for the course.

ONS Safe Handling of Hazardous Drugs Online Course
Safe Handling of Hazardous Drugs is an informative course providing the quality instruction you expect from ONS in a new, convenient format. The classes are faculty-mediated programs, allowing students to interact directly with the faculty through e-mail and chat forums. Working along with the text, students will engage in self-paced reading assignments, activities, and learning opportunities. Students will interact with faculty through e-mails, chat forums, and ongoing evaluation of assignments. The student forums will provide opportunities to share expertise with colleagues. Learn more about the course at the link above.

PODCAST: New Drugs in Cancer Therapy ( 00:42:24 min. )
Caroline Clark will be presenting Bevacizumab: A New Treatment for Non-Small Cell Lung Cancer; Kena Miller will be presenting; Clinical Characteristics and Management Strategy of Revlimid-Induced Tumor Flare Reaction in Patients With CLL.

WEBCAST: Clinical Breakthroughs in EGFR Inhibition: Applying the Science to Your Clinical Practice
This webcast takes a fascinating look at EGFR inhibition, including an illustrated explanation of cellular changes, a clinical review of promising new treatments, and a comprehensive discussion of side effects and their management. Participants will gain a clear understanding of how side effects correlate with treatment progression and with proven strategies to successfully manage the side effects of EGFR inhibitors.

Other Programs Through ONS

The Individual and the Evidence: Treating Advanced Non-Small cell Lung Cancer
This program offers to oncology nurses timely information to be considered when optimizing treatment plans for patients with non-small cell lung cancer. The goal of the oncology nurse is to tailor the treatment plan to the patient in an effort to optimize clinical outcomes while maximizing the patient's quality of life. Through the use of case studies, the participant will gain an understanding of applying the latest treatment options for non-small cell lung cancer to individual patient situations. For more information on scheduling this program for your chapter or institution, please contact us toll free at 888-637-7787 or email ONS with EVIDENCE in the subject line.

Clinical Breakthroughs in EGFR Inhibition: Applying Science to Your Clinical Practice
What are the hottest new clinical developments in targeted therapies? This program takes a fascinating look at EGFR inhibition, including an illustrated explanation of cellular changes, a clinical review of promising new treatments, and a comprehensive discussion of side effects and their management. You'll gain a clear understanding of how side effects correlate with treatment progression and take home proven strategies to successfully manage the side effects of EGFR inhibitors. For more information on scheduling this program for your chapter or institution, please contact us toll free at 888-637-7787 or email ONS with EGFR in the subject line.

Fighting Angiogenesis in Solid Tumors: New Research, Promising Agents
Angiogenesis is the process through which a tumor attempts to gain its own blood supply, thus supplying nutrients and promoting tumor growth. This can be accomplished by stimulating growth factors on the cell endothelium. Cancer therapies aim to block angiogenesis. Targeting vascular endothelial growth factors (VEGF) is one means of accomplishing this. VEGF plays a critical role in cell growth and apoptosis-in both normal and cancerous cells. Targeting VEGF is proving to be a successful way to treat colorectal, breast, and non-small cell lung cancers. In this program, you'll learn about:

• The mechanism of action of anti-VEGF therapies
• The use of anti-VEGF in solid tumors
• The nursing implications for these targeted agents

Small Molecules in the Treatment of Non-Small Cell Lung Cancer
Lung cancer is the most common cause of cancer-related death in men and women. Less than 15% of those diagnosed with lung cancer will be alive after five years; the five-year survival rate drops to less than 6% with a diagnosis of advanced lung cancer. Thus, treatment goals have centered on improving quality of life and prolonging survival. With the advent of targeted therapies in treating non-small cell lung cancer (NSCLC), prolonging survival, with quality, is possible. Epidermal growth factors (EGF) are normal proteins that regulate cell growth, differentiation, and survival. Dysregulation of these growth factors is associated with a poor prognosis in NSCLC. Inhibiting epidermal growth factor receptors (EGFR) may inhibit tumor growth, as demonstrated in NSCLC, head and neck, ovarian, and colon cancers. This program will discuss the role of targeting EGFR with small molecule targeted therapies in NSCLC, including a comprehensive discussion on the mechanism of action, associated side effects and management strategies, and additional nursing implications. For more information on scheduling this program for your chapter or institution, please contact us toll free at 888-637-7787 or email ONS with NSCLC in the subject line.